These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24583676)

  • 1. Possible effects of rosuvastatin on noise-induced oxidative stress in rat brain.
    Ersoy A; Koc ER; Sahin S; Duzgun U; Acar B; Ilhan A
    Noise Health; 2014; 16(68):18-25. PubMed ID: 24583676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is rosuvastatin protective against on noise-induced oxidative stress in rat serum?
    Koc ER; Ersoy A; Ilhan A; Erken HA; Sahın S
    Noise Health; 2015; 17(74):11-6. PubMed ID: 25599753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin ameliorates early brain injury after subarachnoid hemorrhage via suppression of superoxide formation and nuclear factor-kappa B activation in rats.
    Uekawa K; Hasegawa Y; Ma M; Nakagawa T; Katayama T; Sueta D; Toyama K; Kataoka K; Koibuchi N; Kawano T; Kuratsu J; Kim-Mitsuyama S
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1429-39. PubMed ID: 24529602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin.
    Ajith TA; Riji T; Anu V
    Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):625-9. PubMed ID: 18177480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rosuvastatin on obesity-induced cardiac oxidative stress in Wistar rats--a preliminary study.
    Ansari JA; Bhandari U; Pillai KK; Haque SE
    Indian J Exp Biol; 2012 Mar; 50(3):216-22. PubMed ID: 22439437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eNOS/Hsp70 interaction on rosuvastatin cytoprotective effect in neonatal obstructive nephropathy.
    Manucha W; Kurbán F; Mazzei L; Benardón ME; Bocanegra V; Tosi MR; Vallés P
    Eur J Pharmacol; 2011 Jan; 650(2-3):487-95. PubMed ID: 20940012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose.
    Piconi L; Corgnali M; Da Ros R; Assaloni R; Piliego T; Ceriello A
    J Diabetes Complications; 2008; 22(1):38-45. PubMed ID: 18191076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats.
    Ucak A; Onan B; Güler A; Sahin MA; Kılıçkaya O; Oztaş E; Uysal B; Arslan S; Yılmaz AT
    Ann Vasc Surg; 2011 Jul; 25(5):686-95. PubMed ID: 21724106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats].
    Sicard P; Lauzier B; Oudot A; Busseuil D; Collin B; Duvillard L; Moreau D; Vergely C; Rochette L
    Arch Mal Coeur Vaiss; 2005; 98(7-8):804-8. PubMed ID: 16220751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of combined therapy with rosuvastatin and amitriptyline on the oxidation-reduction status in rats.
    Herbet M; Gawrońska-Grzywacz M; Graca A; Jagiełło-Wójtowicz E
    Acta Pol Pharm; 2013; 70(5):913-7. PubMed ID: 24147371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of antioxidant defense mechanism by pitavastatin and rosuvastatin on obesity-induced oxidative stress in Wistar rats.
    Ansari JA; Bhandari U; Haque SE; Pillai KK
    Toxicol Mech Methods; 2012 Jan; 22(1):67-73. PubMed ID: 21859367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
    Whaley-Connell A; DeMarco VG; Lastra G; Manrique C; Nistala R; Cooper SA; Westerly B; Hayden MR; Wiedmeyer C; Wei Y; Sowers JR
    Am J Nephrol; 2008; 28(1):67-75. PubMed ID: 17914247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats.
    Olteanu D; Nagy A; Dudea M; Filip A; Muresan A; Catoi C; Mircea PA; Clichici S
    J Physiol Pharmacol; 2012 Oct; 63(5):483-96. PubMed ID: 23211302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin suppresses the oxidative response in the venous limb of an arteriovenous fistula and enhances the fistula blood flow in diabetic rats.
    Fang SY; Roan JN; Lin Y; Hsu CH; Chang SW; Huang CC; Tsai YC; Lam CF
    J Vasc Res; 2014; 51(2):81-9. PubMed ID: 24434545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders.
    Mahalwar R; Khanna D
    Eur J Pharmacol; 2013 Jul; 711(1-3):57-62. PubMed ID: 23648561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis.
    Schupp N; Schmid U; Heidland A; Stopper H
    Atherosclerosis; 2008 Aug; 199(2):278-87. PubMed ID: 18154958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in brain and antioxidant activity of Ocimum sanctum in noise exposure.
    Samson J; Sheeladevi R; Ravindran R
    Neurotoxicology; 2007 May; 28(3):679-85. PubMed ID: 17379314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
    Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
    J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
    Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
    Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.
    Schäfer A; Fraccarollo D; Vogt C; Flierl U; Hemberger M; Tas P; Ertl G; Bauersachs J
    Biochem Pharmacol; 2007 May; 73(9):1367-75. PubMed ID: 17270148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.